We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.35%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+16.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$9.38B
Cap. Flow %
6.92%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Energy 8.49%
2 Technology 6.67%
3 Healthcare 6.67%
4 Financials 6.58%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMA
3501
DELISTED
NUVEEN MUNI ADVANTAGE FUND
NMA
$1.07M ﹤0.01%
79,359
-43,143
-35% -$587K
CHRD icon
3502
PUT
Chord Energy
CHRD
$7.39B
$1.07M ﹤0.01%
25,600
-77,500
-75% -$3.86M
ALU
3503
DELISTED
Alcatel-Lucent
ALU
$1.07M ﹤0.01%
353,102
-105,202
-23% -$359K
RXI icon
3504
iShares Global Consumer Discretionary ETF
RXI
$278M
$1.07M ﹤0.01%
13,232
-10,471
-44% -$872K
FMC icon
3505
FMC
FMC
$1.33B
$1.07M ﹤0.01%
21,515
-1,488,535
-99% -$84.7M
XLV icon
3506
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
$1.07M ﹤0.01%
16,700
-43,300
-72% -$2.71M
JJE
3507
DELISTED
iPath Bloomberg Energy Subindex Total Return ETN due October 22, 2037
JJE
$1.07M ﹤0.01%
62,719
+18,483
+42% +$329K
SPNT icon
3508
SiriusPoint
SPNT
$2.68B
$1.06M ﹤0.01%
73,096
+54,636
+296% +$837K
BKEP
3509
DELISTED
Blueknight Energy Partners L.P.
BKEP
$1.06M ﹤0.01%
128,798
+89,063
+224% +$769K
CEL
3510
DELISTED
Cellcom Israel, Ltd.
CEL
$1.06M ﹤0.01%
96,689
+89,407
+1,228% +$1.06M
FBR
3511
DELISTED
Fibria Celulose Sa
FBR
$1.06M ﹤0.01%
96,577
-6,763
-7% -$70.1K
NTUS
3512
DELISTED
Natus Medical Inc
NTUS
$1.06M ﹤0.01%
35,945
+1,930
+6% +$53.3K
AEM icon
3513
CALL
Agnico Eagle Mines
AEM
$90.5B
$1.06M ﹤0.01%
36,500
-2,100
-5% -$78.1K
JAZZ icon
3514
PUT
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.06M ﹤0.01%
6,600
-160,200
-96% -$24.6M
QDF icon
3515
FlexShares Quality Dividend Index Fund
QDF
$2.28B
$1.06M ﹤0.01%
30,430
+4,488
+17% +$158K
FXC icon
3516
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.6M
$1.06M ﹤0.01%
11,913
-21,799
-65% -$1.99M
MUH
3517
DELISTED
Blackrock Muniholdings Fund II, Inc.
MUH
$1.06M ﹤0.01%
70,599
+34,394
+95% +$516K
CLDX icon
3518
PUT
Celldex Therapeutics
CLDX
$3.28B
$1.06M ﹤0.01%
5,433
+5,360
+7,342% +$1.17M
AMD icon
3519
Advanced Micro Devices
AMD
$789B
$1.05M ﹤0.01%
309,219
-49,217
-14% -$199K
SMOG icon
3520
VanEck Low Carbon Energy ETF
SMOG
$134M
$1.05M ﹤0.01%
17,715
-2,814
-14% -$178K
WST icon
3521
West Pharmaceutical
WST
$24.9B
$1.05M ﹤0.01%
23,565
+23,096
+4,925% +$981K
NNY icon
3522
Nuveen New York Municipal Value Fund
NNY
$157M
$1.05M ﹤0.01%
108,349
-16,503
-13% -$162K
SRLP
3523
DELISTED
SPRAGUE RESOURCES LP
SRLP
$1.05M ﹤0.01%
41,376
+1,725
+4% +$42.9K
FCB
3524
DELISTED
FCB Financial Holdings, Inc.
FCB
$1.05M ﹤0.01%
+46,282
New +$1.02M
PHI icon
3525
PLDT
PHI
$4.33B
$1.05M ﹤0.01%
15,220
-6,720
-31% -$486K

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.